Secondary analysis of EMPEROR-Preserved (5,988 patients, HFmrEF/HFpEF): empagliflozin's benefit on CV death or HF hospitalisation was greater at higher baseline magnesium (top quintile HR 0.60; lowest HR 1.05; P-trend 0.030).
Secondary analysisn = 5,988
Ferreira et al. Serum Magnesium, Outcomes, and the Effect of Empagliflozin in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Findings From EMPEROR-Preserved